Replies to post #88193 on Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

4. Racially unacceptable therapy.
What if the scientists and doctors came to a conclusion that this personalized therapy requires not just a genome sequencing but also is very sensitive to the race of the person. The therapy works for one race and would not for the other. Would you consider that type of controversial therapy to even take to the later stages of the clinical trials let alone discuss in the public forums? Both companies would be immediately attacked by media and social activists.
5. Amgen learned that this is the cure and did not want to the footsteps of Gilead with Havroni and Sovaldi.
6. Sean Harper wanted to take this tech private and made sure Amgen dumps it after him leaving the company. Once the Advaxis share price crashes he gets to buy it for two peanuts.